Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Pilot Clinical Trial of the Effects in Oxygenation and Hypoxic Pulmonary Vasoconstriction of Sevoflurane in Patient's Whit ARDS Secondary to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2)

NCT04998253 is registered in ClinicalTrials.gov with Unidad Temporal COVID-19 en Centro Citibanamex as lead sponsor.

NCT NCT04998253
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04998253 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Pilot Clinical Trial of the Effects in Oxygenation and Hypoxic Pulmonary Vasoconstriction of Sevoflurane in Patient's Whit ARDS Secondary to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2)
Lead sponsor
Unidad Temporal COVID-19 en Centro Citibanamex
Phase
Phase 1
Overall status
Completed
Start date
October 1, 2020
Completion date
May 15, 2021
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory distress syndrome, hypoxemia, hypoxic pulmonary vasoconstriction, sars-cov-2 acute respiratory disease